103 related articles for article (PubMed ID: 19262429)
1. Focal macular electroretinograms after photodynamic therapy combined with posterior juxtascleral triamcinolone acetonide.
Ishikawa K; Nishihara H; Ozawa S; Piao CH; Ito Y; Kondo M; Terasaki H
Retina; 2009 Jun; 29(6):803-10. PubMed ID: 19262429
[TBL] [Abstract][Full Text] [Related]
2. Effect of posterior juxtascleral triamcinolone acetonide on the efficacy and choriocapillaris hypoperfusion of photodynamic therapy.
Iriyama A; Obata R; Inoue Y; Takahashi H; Tamaki Y; Yanagi Y
Graefes Arch Clin Exp Ophthalmol; 2008 Mar; 246(3):339-44. PubMed ID: 17805556
[TBL] [Abstract][Full Text] [Related]
3. Correlation between focal macular electroretinograms and angiographic findings after photodynamic therapy.
Ishikawa K; Kondo M; Ito Y; Kikuchi M; Nishihara H; Piao CH; Sugita T; Terasaki H
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2254-9. PubMed ID: 17460288
[TBL] [Abstract][Full Text] [Related]
4. Effect of photodynamic therapy alone or combined with posterior subtenon triamcinolone acetonide or intravitreal bevacizumab on choroidal hypofluorescence by indocyanine green angiography.
Hatta Y; Ishikawa K; Nishihara H; Ozawa S; Ito Y; Terasaki H
Retina; 2010 Mar; 30(3):495-502. PubMed ID: 19996828
[TBL] [Abstract][Full Text] [Related]
5. Focal macular electroretinograms after photodynamic therapy combined with intravitreal bevacizumab.
Ishikawa K; Nishihara H; Ozawa S; Piao CH; Ito Y; Kondo M; Terasaki H
Graefes Arch Clin Exp Ophthalmol; 2011 Feb; 249(2):273-80. PubMed ID: 21038080
[TBL] [Abstract][Full Text] [Related]
6. Effect of posterior juxtascleral triamcinolone acetonide on choroidal neovascular growth after photodynamic therapy with verteporfin.
Van de Moere A; Sandhu SS; Kak R; Mitchell KW; Talks SJ
Ophthalmology; 2005 Nov; 112(11):1896-903. PubMed ID: 16214216
[TBL] [Abstract][Full Text] [Related]
7. Prolongation of choroidal hypofluorescence following combined verteporfin photodynamic therapy and intravitreal triamcinolone acetonide injection.
Luttrull JK; Spink CJ
Retina; 2007; 27(6):688-92. PubMed ID: 17621176
[TBL] [Abstract][Full Text] [Related]
8. Triamcinolone acetonide as adjunctive treatment to verteporfin in neovascular age-related macular degeneration: a prospective randomized trial.
Chaudhary V; Mao A; Hooper PL; Sheidow TG
Ophthalmology; 2007 Dec; 114(12):2183-9. PubMed ID: 18054638
[TBL] [Abstract][Full Text] [Related]
9. Time-course and characteristic morphology of retinal changes following combination of verteporfin therapy and intravitreal triamcinolone in neovascular age-related macular degeneration.
Lie S; Aue A; Sacu S; Simader C; Polak K; Schmidt-Erfurth U
Acta Ophthalmol; 2010 Mar; 88(2):212-7. PubMed ID: 19016662
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy combined with low-dose intravitreal triamcinolone acetonide for age-related macular degeneration refractory to photodynamic therapy alone.
Iwama D; Otani A; Sasahara M; Yodoi Y; Gotoh N; Tamura H; Tsujikawa A; Yoshimura N
Br J Ophthalmol; 2008 Oct; 92(10):1352-6. PubMed ID: 18662914
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization.
Spaide RF; Sorenson J; Maranan L
Ophthalmology; 2005 Feb; 112(2):301-4. PubMed ID: 15691567
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of photodynamic therapy combined with intravitreal triamcinolone acetonide (TA) for treatment of occult choroidal neovascularization secondary to age-related macular degeneration.
Ho TC
Retina; 2006; 26(6):714; author reply 715. PubMed ID: 16829825
[No Abstract] [Full Text] [Related]
13. Photodynamic therapy with intravitreal triamcinolone in predominantly classic choroidal neovascularization: one-year results of a randomized study.
Arias L; Garcia-Arumi J; Ramon JM; Badia M; Rubio M; Pujol O
Ophthalmology; 2006 Dec; 113(12):2243-50. PubMed ID: 16996600
[TBL] [Abstract][Full Text] [Related]
14. Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration.
Augustin AJ; Schmidt-Erfurth U
Ophthalmology; 2006 Jan; 113(1):14-22. PubMed ID: 16360209
[TBL] [Abstract][Full Text] [Related]
15. Indocyanine green-mediated photothrombosis with intravitreal triamcinolone acetonide for subfoveal choroidal neovascularization in age-related macular degeneration.
Arevalo JF; Garcia RA; Mendoza AJ
Graefes Arch Clin Exp Ophthalmol; 2005 Nov; 243(11):1180-5. PubMed ID: 15906068
[TBL] [Abstract][Full Text] [Related]
16. Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration.
Augustin AJ; Schmidt-Erfurth U
Am J Ophthalmol; 2006 Apr; 141(4):638-45. PubMed ID: 16564797
[TBL] [Abstract][Full Text] [Related]
17. Periocular triamcinolone and photodynamic therapy for subfoveal choroidal neovascularization in age-related macular degeneration.
; Gilson MM; Bressler NM; Jabs DA; Solomon SD; Thorne JE; Wilson DJ
Ophthalmology; 2007 Sep; 114(9):1713-21. PubMed ID: 17822977
[TBL] [Abstract][Full Text] [Related]
18. Anatomical and visual outcome of retinal angiomatous proliferation treated with photodynamic therapy and intravitreal triamcinolone.
van de Moere A; Kak R; Sandhu SS; Talks SJ
Am J Ophthalmol; 2007 Apr; 143(4):701-4. PubMed ID: 17386286
[TBL] [Abstract][Full Text] [Related]
19. Color Doppler imaging of ocular blood flow after combined photodynamic therapy with intravitreal triamcinolone in age-related macular degeneration.
Cekiç O; Bardak Y; Yeşildağ A
Curr Eye Res; 2011 Feb; 36(2):149-53. PubMed ID: 21158585
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide in the treatment of neovascular age-related macular degeneration.
Ergun E; Maár N; Ansari-Shahrezaei S; Wimpissinger B; Krepler K; Wedrich A; Stur M
Am J Ophthalmol; 2006 Jul; 142(1):10-16. PubMed ID: 16815246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
